Each Coartem Dispersible tablet contains 20 mg of artemether and 120 mg of lumefantrine. Coartem Dispersible belongs to the group of medicines known as anti-malarials, i.e. medicines used to treat certain types of malaria infections. It destroys the malaria parasites (tiny organisms consisting of a single cell that are found inside the red blood cells). Coartem/Riamet Dispersible is used to treat infants and children with malaria infections caused by Plasmodium falciparum (a particular type of malaria parasite) or with mixed infections that include Plasmodium falciparum. Coartem/Riamet Dispersible is also recommended for malaria infections acquired in areas where malaria parasites may be resistant to other anti-malarial medicines. Most tourists and travelers, who are considered to be non-immune (i.e. they have no immune protection against malaria), will be able to get prompt medical attention if malaria is suspected. However, a small number of children at risk of infection may be unable to obtain such care within 24 hours of the onset of symptoms, particularly if they are in an isolated location far from medical services. In such cases, the parent or caregiver is given Coartem/Riamet Dispersible by their doctor to administer to the travelling child (= “standby emergency treatment”).